dexmedetomidine has been researched along with Breast Neoplasms in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 13 (68.42) | 24.3611 |
2020's | 5 (26.32) | 2.80 |
Authors | Studies |
---|---|
Gaafary, ME; Hafner, S; Huber, R; Lang, SJ; Paetz, C; Schmidt, CQ; Schmiech, M; Simmet, T; Steinborn, C; Syrovets, T; Werner, K | 1 |
Eldeek, AM; Hefni, AF; Ismael, SA; Shaban, AR | 1 |
Chen, C; Chen, W; Fan, P; Huang, Y; Jin, S; Qi, Z; Qian, L; Zhang, N | 1 |
Demiri, M; Millet, C; Rives, JP; Sciaraffa, C | 1 |
Chang, YJ; Jo, YY; Jung, WS; Kwak, H; Kwon, S; Lee, KC | 1 |
Du, Y; Duan, H; Liu, Y; Lu, J; Lu, X; Su, D; Sun, J; Tian, J; Wu, T; Yu, W | 1 |
Abdel-Ghaffar, HS; Allam, AAAE; El Sherif, FA; Hassan, NA; Hassan, SB; Mohamed, SA; Omran, MM; Sayed, DG; Shouman, SA | 1 |
Liu, C; Shan, Z; Wang, W; Yan, Q; Zhang, H | 1 |
Jin, LJ; Li, G; Sun, P; Wen, LY; Zhang, YL; Zhou, X | 1 |
Abdel-Hamed, MF; Bakr, MA; El Sherif, FA; Mohamad, MF; Mohamed, MA; Mohamed, SA; Mosad, E | 1 |
Berlière, M; De Kock, M; Forget, P; Poncelet, A | 1 |
Liu, T; Wang, X; Yao, Y; Zhang, D | 1 |
Brown, EB; Burke, KA; Dawes, RP; Madden, KS; Szpunar, MJ | 1 |
Bruzzone, A; Copsel, S; Davio, C; Galés, C; Gargiulo, L; Lüthy, IA; Rivero, EM; Sénard, JM | 1 |
Lin, JB; Mast, N; Pikuleva, IA | 1 |
Kalra, B; Kaur, N; Mohta, M; Sethi, AK | 1 |
Duan, ML; Ji, NN; Tong, JH; Wang, SH; Xia, M; Xu, JG; Zhang, YM | 1 |
Gužvinec, Z; Lozić, M; Miklić Bublić, M; Stambolija, V; Vukić, M | 1 |
Ito, T; Kawamoto, M; Kusunom, S; Yuge, O | 1 |
1 review(s) available for dexmedetomidine and Breast Neoplasms
Article | Year |
---|---|
Dexmedetomidine as an adjuvant for patients undergoing breast cancer surgery: A meta-analysis.
Topics: Analgesics, Opioid; Breast Neoplasms; Dexmedetomidine; Female; Hemodynamics; Humans; Mastectomy; Odds Ratio; Pain Measurement; Pain, Postoperative; Postoperative Nausea and Vomiting; Randomized Controlled Trials as Topic | 2020 |
7 trial(s) available for dexmedetomidine and Breast Neoplasms
Article | Year |
---|---|
Comparing Effect of Adding Ketamine Versus Dexmedetomidine to Bupivacaine in Pecs-ⅠⅠ Block on Postoperative Pain Control in Patients Undergoing Breast Surgery.
Topics: Anesthetics, Local; Breast Neoplasms; Bupivacaine; Dexmedetomidine; Double-Blind Method; Female; Humans; Ketamine; Mastectomy; Morphine; Pain, Postoperative; Prospective Studies | 2022 |
Antiemetic efficacy of dexmedetomidine versus dexmedetomidine-dexamethasone combination in patients undergoing breast surgery.
Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Dexamethasone; Dexmedetomidine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Incidence; Mastectomy; Middle Aged; Postoperative Nausea and Vomiting; Young Adult | 2019 |
Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Analgesics, Non-Narcotic; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Combined Modality Therapy; Dexmedetomidine; Female; Humans; Middle Aged; Neoplasm Staging; Perioperative Period | 2019 |
Pharmacokinetics and Pharmacodynamics of 3 Doses of Oral-Mucosal Dexmedetomidine Gel for Sedative Premedication in Women Undergoing Modified Radical Mastectomy for Breast Cancer.
Topics: Administration, Buccal; Adult; Breast Neoplasms; Dexmedetomidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Compounding; Egypt; Female; Gels; Hemodynamics; Humans; Hypnotics and Sedatives; Mastectomy, Modified Radical; Middle Aged; Oral Mucosal Absorption; Premedication; Prospective Studies; Treatment Outcome | 2021 |
Thoracic paravertebral regional anesthesia for pain relief in patients with breast cancer surgery.
Topics: Aged; Analgesics, Non-Narcotic; Anesthesia, Epidural; Anesthetics, Local; Breast Neoplasms; Bupivacaine; Dexmedetomidine; Female; Humans; Middle Aged; Pain Measurement; Pain, Postoperative; Thoracic Vertebrae; Treatment Outcome | 2017 |
Effect of Dexmedetomidine Added to Modified Pectoral Block on Postoperative Pain and Stress Response in Patient Undergoing Modified Radical Mastectomy.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Breast Neoplasms; Dexmedetomidine; Double-Blind Method; Female; Humans; Mastectomy, Modified Radical; Middle Aged; Nerve Block; Pain Management; Pain, Postoperative; Prospective Studies; Stress, Physiological; Young Adult | 2018 |
Efficacy of dexmedetomidine as an adjuvant in paravertebral block in breast cancer surgery.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Anesthesia, General; Breast Neoplasms; Bupivacaine; Dexmedetomidine; Double-Blind Method; Female; Fentanyl; Humans; Mastectomy; Mastectomy, Modified Radical; Middle Aged; Morphine; Nerve Block; Pain, Postoperative; Postoperative Nausea and Vomiting; Prospective Studies | 2016 |
11 other study(ies) available for dexmedetomidine and Breast Neoplasms
Article | Year |
---|---|
Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisia annua; Artemisinins; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Female; Flavones; Flavonoids; Humans; Leukocytes, Mononuclear; Lung Neoplasms; Mice; Mice, Nude; Plant Extracts; Xenograft Model Antitumor Assays | 2019 |
Dexmedetomidine provides type-specific tumour suppression without tumour-enhancing effects in syngeneic murine models.
Topics: Animals; Breast Neoplasms; CD8-Positive T-Lymphocytes; Colorectal Neoplasms; Dexmedetomidine; Disease Models, Animal; Female; Humans; Lung Neoplasms; Mice | 2023 |
Perioperative polyuria associated with dexmedetomidine administration during reconstruction breast surgery.
Topics: Breast Neoplasms; Dexmedetomidine; Female; Humans; Polyuria | 2023 |
Effect of clonidine on oncological outcomes after breast and lung cancer surgery.
Topics: Animals; Breast Neoplasms; Clonidine; Colonic Neoplasms; Dexmedetomidine; Humans; Lung Neoplasms; Rodentia | 2018 |
The Contrary Effects of Sirt1 on MCF7 Cells Depend on CD36 Expression Level.
Topics: Adrenergic alpha-2 Receptor Agonists; Breast; Breast Neoplasms; CD36 Antigens; Cell Proliferation; Dexmedetomidine; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Resveratrol; Signal Transduction; Sirtuin 1; Up-Regulation | 2019 |
The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.
Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Antidepressive Agents, Tricyclic; Apoptosis; Breast Neoplasms; Cell Proliferation; Collagen; Cytokines; Desipramine; Dexmedetomidine; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence, Multiphoton; Norepinephrine; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured | 2013 |
Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.
Topics: Adrenergic beta-2 Receptor Agonists; Breast Neoplasms; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Dexmedetomidine; Disease Progression; Epinephrine; Female; Gene Knockdown Techniques; Humans; Isoproterenol; MCF-7 Cells; Phenotype; Receptors, Adrenergic, beta-2; Signal Transduction; Transfection | 2014 |
Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant Therapy.
Topics: Adjuvants, Pharmaceutic; Anastrozole; Anilides; Animals; Antifungal Agents; Antineoplastic Agents; Breast Neoplasms; Cholestanetriol 26-Monooxygenase; Dexmedetomidine; Enzyme Inhibitors; Fadrozole; Female; Hypnotics and Sedatives; Mice; Mice, Inbred C57BL; Nitriles; Protein Binding; Thiazoles; Tosyl Compounds; Triazoles | 2015 |
Dexmedetomidine regulate the malignancy of breast cancer cells by activating α2-adrenoceptor/ERK signaling pathway.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dexmedetomidine; Female; Humans; Signal Transduction | 2016 |
Analgosedation With Dexmedetomidine in a Patient With Superior Vena Cava Syndrome in Neurosurgery.
Topics: Analgesia; Brain Neoplasms; Breast Neoplasms; Conscious Sedation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Middle Aged; Neurosurgical Procedures; Superior Vena Cava Syndrome | 2018 |
[Validity of intraoperative administration of dexmedetomidine in a patient with dermatomyositis-derived respiratory failure].
Topics: Aged; Analgesics, Non-Narcotic; Anesthesia, Epidural; Breast Neoplasms; Dermatomyositis; Dexmedetomidine; Female; Humans; Intraoperative Care; Mastectomy; Respiratory Insufficiency | 2006 |